WHO policy brief: Clinical management of COVID-19
10 December 2024
| COVID-19: Clinical care
/epidemic-and-pandemic-preparedness-and-prevention-(epp)/emerging-diseases-and-zoonoses-(ezd)/clinical-care_thumbnail.tmb-479v.png?sfvrsn=f99c649_1)
Overview
- Establishing and sustaining clear pathways to clinical care remains a critical element of the response to COVID-19.
- As per the WHO Director-General’s standing recommendations, countries are encouraged to deliver optimal clinical care for COVID-19, appropriately integrated into all levels of health service, including access to proven treatments. Individuals who test positive for SARS-CoV-2 should be immediately linked to a clinical care pathway.
- Countries should adapt COVID-19 clinical care pathways for women who are pregnant or breastfeeding and children.
- Countries are encouraged to provide access to follow-up care to detect post COVID-19 condition (also known as long COVID or PCC).
- Countries should plan for COVID-19 surges using estimation tools for essential supplies, equipment and the work force.
Related links
WHO Team
Epidemic and Pandemic Preparedness and Prevention (EPP)
Number of pages
5